North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
|Articles|August 1, 1999
Supplements and Featured Publications
- Vascular Compliance: Clinical and Managed Care Issues
- Volume 5
- Issue 12 Suppl
Participating Faculty
Advertisement
Articles in this issue
about 27 years ago
Introductionabout 27 years ago
Can Arterial Stiffness be Reversed? And If So, What are the Benefits?about 27 years ago
Perindopril: Clinical Profile of a Unique ACE Inhibitorabout 27 years ago
Issues in Vascular Complianceabout 27 years ago
Selected Abstractsabout 27 years ago
BibliographyAdvertisement
Related to this article
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A follicular lymphoma survivor shares axi-cel CAR T-cell therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improve quality of life.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
Advertisement
Advertisement
Trending on AJMC
1
Tavapadon for Parkinson Disease Approved by FDA
2
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
3
DME Drug Remigromig Hits Primary End Point in Phase 3 Trial
4
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
5